IQVIA share price logo

IQVIA

NASDAQ: IQV

Large Cap

$167.77

-2.90

(-1.70%)

as on

IQVIA Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $162.22
    $171.00
    downward going graph

    3.31%

    Downside

    1.93%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $153.01
    $247.05
    downward going graph

    8.80%

    Downside

    47.25%

    Upside

    downward going graph

IQVIA share price movements today

Previous Close
$170.67
Open
$170.50
Volume
2.1M
Day's Low - High
$162.22 - $171.00
52 Week Low - High
$153.01 - $247.05

IQVIA Historical Returns

1 Month Return
-0.08 %
3 Month Return
+ 1.02 %
1 Year Return
+ 8.43 %
3 Year Return
-21.46 %
5 Year Return
-31.24 %

IQVIA Stock Fundamentals & Key Indicators

Check IQVIA market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.0B

EPS (TTM)

12.8128

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.15%

PE Ratio (TTM)

20.84

Industry PE ratio

9.453333333333333

PEG Ratio

0.6761

EBITDA

3.0B

Revenue (TTM)

16.6B

Profit Margin

8.33%

Return On Equity TTM

22.49%

IQVIA Stock Valuation

Track how IQVIA P/E has moved over time to understand its valuation trends.

IQVIA in the last 5 years

  • Overview

  • Trends

Lowest (16.90x)

June 30, 2025

Industry (9.45x)

June 22, 2026

Today (20.84x)

June 22, 2026

Highest (29.38x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 20.84x

IQVIA vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of IQVIA with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$28.0B-31.24%20.848.33%NA
BUY$44.3B-8.1%41.3324.63%NA
BUY$35.9B-13.35%25.5119.55%0.8099999999999999%
BUY$172.7B-5.61%25.5115.15%0.38%
BUY$125.4B-33.65%34.3414.89%0.77%

Stock Returns calculator for IQVIA Stock including INR - Dollar returns

The IQVIA stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

IQVIA investment value today

Current value as on today

₹1,18,108

Returns

₹18,108

(+18.11%)

Returns from IQVIA Stock

₹8,428 (+8.43%)

Dollar Impact

₹9,681 (+9.68%)

Analyst Recommendation on IQVIA Stock

Based on 26 analysts

BUY

76.92%

Buy

23.08%

Hold

0.00%

Sell

Based on 26 analysts, 76.92% of analysts recommend a 'BUY' rating for IQVIA. Average target price of $225.47

IQVIA Share Price Target

Get share price movements and forecasts by analysts on IQVIA.

What analysts predicted

25.59%UPSIDE

Target Price

$225.47

Current Price

$167.77

Analyzed by

26 Analysts

Target

$225.47

IQVIA target price $225.47, a slight upside of 25.59% compared to current price of $167.77. According to 26 analysts rating.

Indian Investors' Interest in IQVIA Stock

Search interest for IQVIA Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-7% versus previous 30 day period

IQVIA Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
3,868
3,737
3,814
3,896
3,958
3,829
4,017
4,100
4,364
4,151
Gross Profit
1,390
1,293
1,057
1,378
1,378
1,298
1,323
1,373
292
1,355
Operating Income
501
506
548
550
626
496
506
553
732
514
EBITDA
870
767
883
797
1,018
753
781
883
1,047
808
Interest Expense
181
166
163
170
171
165
182
189
193
192
Depreciation
316
264
269
278
303
265
276
286
317
288
Income Before Tax
367
337
438
350
549
310
323
408
572
328
Income Tax Expense
-102
49
75
65
112
61
57
76
58
59
Net Income
469
288
363
285
437
249
266
331
514
274
Net Profit Margin
12.13%
7.71%
9.52%
7.32%
11.04%
6.50%
6.62%
8.07%
11.78%
6.60%

IQVIA Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6,815
9,702
10,412
11,088
11,359
13,874
14,410
14,984
15,405
16,310
Gross Profit
2,067
3,401
3,666
3,788
3,859
4,641
5,028
5,239
5,375
4,286
Operating Income
642
719
741
777
731
1,393
1,799
1,977
2,202
2,287
EBITDA
849
1,651
1,883
2,001
2,076
2,767
2,909
3,256
3,453
3,464
Interest Expense
144
346
414
447
416
375
416
672
670
729
Depreciation
-
1,011
1,141
1,202
1,287
1,264
1,130
1,125
1,114
1,144
Income Before Tax
412
304
343
343
380
1,134
1,351
1,459
1,669
1,613
Income Tax Expense
345
-987
59
116
72
163
260
101
296
252
Net Income
115
1,309
259
191
279
966
1,091
1,358
1,373
1,360
Net Profit Margin
1.69%
13.49%
2.49%
1.72%
2.46%
6.96%
7.57%
9.06%
8.91%
8.34%

IQVIA Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
288
363
285
437
249
266
332
514
275
Operating Cash Flow
522
588
721
885
568
443
908
735
618
Investing Cash Flow
-314
-221
-599
-310
-305
-346
-550
-1,104
-196
Financing Cash Flow
-106
-260
-137
-375
-258
145
-572
535
-433
Change in Cash
68
101
27
130
38
299
-225
166
-33

IQVIA Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
1,328
284
227
308
966
1,091
1,358
1,373
1,361
Operating Cash Flow
970
1,254
1,417
1,959
2,942
2,260
2,149
2,716
2,654
Investing Cash Flow
-1,190
-810
-1,190
-796
-2,103
-2,006
-1,603
-1,444
-2,305
Financing Cash Flow
-72
-452
-276
-217
-1,235
-329
-382
-878
-150
Change in Cash
-239
-68
-54
977
-448
-150
160
326
278

Mutual Funds that own IQVIA Stock

Check out the Mutual Funds with significant holdings in IQVIA.

Global Institutional Holdings in IQVIA

Funds
Holdings
Deutsche Bank AG
0.51%
Harris Associates L.P.
7.3%
Artisan Partners Limited Partnership
3.03%
Boston Partners Global Investors, Inc
2.54%
Longview Partners (Guernsey) Limited
1.14%

IQVIA News & Key Events

  • img

    Today's Timeline - 17 June

    Wed, 03:02 PM

    -

    IQVIA shares fell to $177.52, reflecting a 19.8% loss over six months, underperforming the S&P 500.

    Wed, 09:50 PM

    -

    IQVIA's 12-month price target cut to $223.28, indicating a potential 25% upside; consensus rating remains at Buy.

Insights on IQVIA

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Thermo Fisher Scientific, Inc. has given 16.8% return, outperforming this stock by 8.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, IQVIA Holdings Inc. has experienced a drawdown of -21.5%, however IDEXX Laboratories, Inc. Common Stock resisted the overall trend and outperformed by 9.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 4.36B → 4.15B (in $), with an average decrease of 4.9% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, IQV stock has moved down by -6.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 514.0M → 274.0M (in $), with an average decrease of 46.7% per quarter

About IQVIA

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.
OrganisationIQVIA
Headquarters2400 Ellis Road, Durham, NC, United States, 27703
IndustryDiagnostics & Research
CEOMr. Ari Bousbib
E-voting on sharesClick here to vote

Key Management of IQVIA

Name

Title

Mr. Duane Sachs

Senior Vice President of Corporate Development

Mr. Eric M. Sherbet J.D.

Executive VP, General Counsel & Secretary

Mr. Alistair Grenfell

President of Commercial Solutions

Kerri Joseph

Senior VP of Investor Relations & Treasurer

Mr. James G. Berkshire

Executive Vice President of Global Infrastructure & Operations

Ms. Keriann Cherofsky

Senior VP, Corporate Controller & Chief Accounting Officer

Dr. Jeffrey A. Spaeder M.D.

Chief Medical & Scientific Officer

Mr. Ari Bousbib

CEO & Chairman

Mr. W. Richard Staub III

President of Research & Development Solutions

Mr. Michael J. Fedock MBA

Executive VP & Chief Financial Officer

FAQs

What is IQVIA share price today?

IQVIA share price today is $167.77 as on at the close of the market. IQVIA share today touched a day high of $171 and a low of $162.22.

What is the 52 week high and 52 week low for IQVIA share?

IQVIA share touched a 52 week high of $247.05 on and a 52 week low of $153.01 on . IQVIA stock price today i.e. is closed at $167.77,which is 32.09% down from its 52 week high and 9.65% up from its 52 week low.

What is IQVIA's market capitalisation today?

IQVIA market capitalisation is $0.03T as on .

How to invest in IQVIA Stock (IQV) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for IQVIA on INDmoney app. Click on Buy button. You can invest as low as $1.5 in IQVIA Shares that will get you 0.0089 shares as per IQVIA share price of $167.77 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy IQVIA Stock (IQV) from India?

Indian investors can start investing in IQVIA (IQV) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in IQVIA stock (as per the Rupee-Dollar exchange rate as on ). Based on IQVIA share’s latest price of $167.77 as on June 19, 2026 at 8:46 am IST, you will get 0.0596 shares of IQVIA. Learn more about fractional shares .

What are the returns that IQVIA has given to Indian investors in the last 5 years?

IQVIA stock has given -31.24% share price returns and 27.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?